FILTER BY:
The approval of aflibercept by the US Food and Drug Administration in Nove…
Expiration Date: 12/1/2013
Max Credits: 0
View Activity
The development of agents capable of inhibiting the angiogenic signaling p…
The evolution in imaging for diagnosis and management of wet age-related m…
A new paradigm has emerged for the management of diabetic macular edema (D…
Expiration Date: 4/10/2013
Diabetic macular edema (DME) is the leading cause of new vision loss in wo…
Expiration Date: 4/25/2013
Diabetic macular edema (DME) is a major cause of decreased vision..
In recent years, there has been a paradigm shift emerging in the treatment…
With more than 1.5 million intravitreal injections done in the United Stat…
Expiration Date: 3/14/2015
Most vascular endothelial growth factor (VEGF) mediated biological activit…
Expiration Date: 3/11/2015
Intravitreal injections have rapidly become one of the most common medical…
Expiration Date: 3/5/2015